Effects of a maternal psychosocial intervention on hair derived biomarkers of HPA axis function in mothers and children in rural Pakistan.
Cortisol
DHEA
HPA axis
Infancy
Intervention
Low and middle income countries
Maternal depression
RCT
Journal
SSM. Mental health
ISSN: 2666-5603
Titre abrégé: SSM Ment Health
Pays: England
ID NLM: 9918248909306676
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
medline:
13
7
2023
pubmed:
13
7
2023
entrez:
13
7
2023
Statut:
ppublish
Résumé
Disruptions in the hypothalamic-pituitary-adrenal (HPA) axis are thought to be key neuroendocrine mechanisms involved in psychopathology and may have intergenerational impacts. Hair-derived HPA hormones offer a measure of long-term HPA axis activity that may be useful in assessing maternal and infant health. Building on a community-based randomized control trial of a perinatal depression intervention in Pakistan, we examine intervention effects on HPA axis activity in a subsample of mothers and infants. HPA axis activity was assessed using hair-derived cortisol, cortisone, and dehydroepiandosterone (DHEA). Hair samples were collected from mother-child dyads at one year postpartum from prenatally depressed women randomized to a cognitive-behavioral intervention (n = 35 dyads) or to enhanced usual care (n = 37 dyads), and from a comparison sample of women who screened negative for depression in pregnancy (n = 35 dyads). The intervention group had 38 percent Results suggest that the perinatal depression intervention has effects on HPA axis activity in both mothers and children, providing evidence that treating maternal depression may impact physiological stress system functioning intergenerationally. In addition, utilizing hair-derived biomarkers of HPA-axis activity is a potentially useful clinical indicator of intervention impacts on the neuroendocrine system.
Identifiants
pubmed: 37441003
doi: 10.1016/j.ssmmh.2022.100082
pmc: PMC10338030
mid: NIHMS1856338
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NICHD NIH HHS
ID : R01 HD075875
Pays : United States
Organisme : NICHD NIH HHS
ID : R03 HD097434
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD007168
Pays : United States
Organisme : NIMH NIH HHS
ID : U19 MH095687
Pays : United States
Déclaration de conflit d'intérêts
Disclosure statement No potential conflict of interest was reported by the authors. Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jun 1;928:1-8
pubmed: 23584040
Horm Behav. 2017 Mar;89:69-85
pubmed: 27979632
Psychoneuroendocrinology. 2019 Mar;101:263-271
pubmed: 30594110
J Child Psychol Psychiatry. 2018 Apr;59(4):327-346
pubmed: 28714126
Biol Psychiatry. 2015 Sep 1;78(5):344-53
pubmed: 25727177
Biol Psychol. 2009 Apr;81(1):31-9
pubmed: 19428966
Psychoneuroendocrinology. 2013 Aug;38(8):1220-35
pubmed: 23253896
Psychoneuroendocrinology. 2011 Sep;36(8):1193-200
pubmed: 21411229
Lancet. 2017 Mar 4;389(10072):951-963
pubmed: 28271846
Life Sci. 2015 Nov 15;141:188-92
pubmed: 26454227
Lancet Psychiatry. 2020 Sep;7(9):775-787
pubmed: 32828167
Soc Sci Med. 2009 Jun;68(12):2180-9
pubmed: 19406546
BMC Psychiatry. 2017 Feb 23;17(1):79
pubmed: 28231791
J Psychosom Res. 2020 Aug;135:110162
pubmed: 32485622
J Psychosom Obstet Gynaecol. 2012 Dec;33(4):162-70
pubmed: 23078196
Front Neuroendocrinol. 2009 Jan;30(1):65-91
pubmed: 19063914
Psychoneuroendocrinology. 2020 Sep;119:104751
pubmed: 32559611
J Affect Disord. 2020 Mar 15;265:660-668
pubmed: 32090783
Q J Econ. 2016 Nov;131(4):1973-2042
pubmed: 33087990
Lancet Psychiatry. 2015 Jul;2(7):609-17
pubmed: 26303558
Psychophysiology. 2020 Jan;57(1):e13271
pubmed: 30101980
BMC Psychiatry. 2020 Jul 15;20(1):370
pubmed: 32669084
Psychosom Med. 2021 Oct 1;83(8):894-905
pubmed: 34259441
Neurosci Biobehav Rev. 2016 Oct;69:124-35
pubmed: 27443960
Steroids. 1999 Sep;64(9):640-7
pubmed: 10503722
Trials. 2015 Nov 25;16:534
pubmed: 26604001
Pediatrics. 2014 Feb;133(2):312-26
pubmed: 24420810
Psychopathology. 2011;44(1):60-7
pubmed: 21072001
Ann N Y Acad Sci. 1999;896:30-47
pubmed: 10681886
Neurosci Biobehav Rev. 2019 Jun;101:32-44
pubmed: 30922979
Psychoneuroendocrinology. 2015 Jan;51:188-200
pubmed: 25462892
Brain Sci. 2019 Jan 23;9(2):
pubmed: 30678071
Psychoneuroendocrinology. 2021 Jul;129:105255
pubmed: 34020263
Brain Behav Immun. 2020 Jul;87:207-217
pubmed: 30797045
Perspect Public Health. 2009 Sep;129(5):221-7
pubmed: 19788165
Psychol Bull. 2007 Jan;133(1):25-45
pubmed: 17201569
BMJ Open. 2019 May 5;9(5):e025644
pubmed: 31061029
Psychoneuroendocrinology. 2018 Dec;98:168-176
pubmed: 30170311
Clin Biochem. 2019 Jan;63:1-9
pubmed: 30261181
Health Psychol Rev. 2021 Mar;15(1):56-84
pubmed: 32635830
Psychoneuroendocrinology. 2009 Jan;34(1):19-26
pubmed: 18805642
Neurosci Biobehav Rev. 2010 Sep;35(1):17-22
pubmed: 19914282
Psychoneuroendocrinology. 2019 Nov;109:104382
pubmed: 31374371
Child Care Health Dev. 2009 Jan;35(1):56-62
pubmed: 18991970
Psychoneuroendocrinology. 2018 Dec;98:86-94
pubmed: 30121549
Biol Psychiatry. 2004 Feb 15;55(4):376-81
pubmed: 14960290
PeerJ. 2018 Jul 17;6:e5185
pubmed: 30038858
Psychoneuroendocrinology. 2017 Apr;78:177-184
pubmed: 28212519
Lancet. 2008 Sep 13;372(9642):902-9
pubmed: 18790313
J Affect Disord. 2020 Nov 1;276:592-599
pubmed: 32871690
J Psychiatr Res. 2010 Feb;44(3):183-92
pubmed: 19747693
J Steroid Biochem Mol Biol. 2019 Apr;188:77-85
pubmed: 30557606
Int J Cardiol. 2015 Apr 1;184:71-78
pubmed: 25705007
Front Psychiatry. 2020 Jul 22;11:728
pubmed: 32793012
Psychoneuroendocrinology. 2011 Nov;36(10):1480-94
pubmed: 21641117
J Altern Complement Med. 2014 Aug;20(8):630-4
pubmed: 24963659
Psychoneuroendocrinology. 2012 May;37(5):589-601
pubmed: 21974976
Glob Ment Health (Camb). 2019 Apr 26;6:e4
pubmed: 31143465
Int J Ment Health Syst. 2019 Sep 17;13:62
pubmed: 31534475
Lancet Psychiatry. 2019 Feb;6(2):128-139
pubmed: 30686386
Psychoneuroendocrinology. 2018 Mar;89:138-146
pubmed: 29358120
PLoS One. 2017 May 9;12(5):e0175923
pubmed: 28486559
Trials. 2016 Sep 08;17(1):442
pubmed: 27608926
Psychoneuroendocrinology. 2009 Jan;34(1):32-7
pubmed: 18947933
Clin Invest Med. 2014 Dec 01;37(6):E403-8
pubmed: 25618273
Psychoneuroendocrinology. 2019 Sep;107:241-250
pubmed: 31174162